Dopaminergic neuroblastoma as a poor prognostic subgroup
- 30 April 1988
- journal article
- case report
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 23 (4) , 346-349
- https://doi.org/10.1016/s0022-3468(88)80204-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicatorJournal of Pediatric Surgery, 1987
- N-myc ONCOGENE AMPLIFICATION AND CATECHOLAMINE METABOLISM CHILDREN WITH NEUROBLASTOMAThe Lancet, 1987
- Intratumorous distribution of catecholaminergic clone cells of human neuroblastomaVirchows Archiv, 1986
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984
- Tumor and urine catecholamines (CATs) in neurogenic tumors: Correlations with other prognostic factors and survivalCancer, 1983
- Initial Urinary Catecholamine Metabolite Concentrations and Prognosis in NeuroblastomaPediatrics, 1978
- Catecholamine Metabolism in Neuroblastoma 1 2JNCI Journal of the National Cancer Institute, 1976
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971